14 Atopic Dermatitis Clinical Trials in Irving, TX (2026)

Q: How do I join a clinical trial in Irving?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Irving research site will contact you.

Recruiting Atopic Dermatitis Studies in Irving

NCT06384352Recruiting

Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

This is a multicenter, open-label, Phase 1 study. The study will enroll subjects with advanced solid tumors. It consists of six parts. Objectives for Dose-Escalation Parts (Part 1 and Part 4) To evalu...

Irving, TXPHASE1500 participantsMediLink Therapeutics (Suzhou) Co., Ltd.

View Study Details

NCT05458219Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic s...

Irving, TXPHASE1470 participantsInnovent Biologics (Suzhou) Co. Ltd.

View Study Details

NCT07066657Recruiting

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

This is an open-label, multi-center, phase I study to evaluate the safety, tolerability, efficacy, and pharmacokinetics of MRG007 (ARR-217) in patients with unresectable locally advanced or metastatic...

Irving, TXPHASE1405 participantsArriVent BioPharma, Inc.

View Study Details

NCT07223125Recruiting

A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors

The purpose of this study is to determine safe and effective dose (recommended phase 2 doses \[RP2Ds\]) of JNJ-89862175 in Part 1 (dose escalation), and to further evaluate how safe JNJ-89862175 is at...

Irving, TXPHASE1360 participantsJanssen Research & Development, LLC

View Study Details

NCT06818643Recruiting

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumor...

Irving, TXPHASE1270 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06657222Recruiting

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the safety of TUB-030. The main questions it aims to answer are: To ...

Irving, TXPHASE1250 participantsTubulis GmbH

View Study Details

NCT07454642Recruiting

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

This is a first-in-human (FIH), Phase 1 open-label, multicenter dose escalation study investigating AVA6103 monotherapy administered intravenously in patients with locally advanced (unresectable) or m...

Irving, TXPHASE1174 participantsAvacta Life Sciences Ltd

View Study Details

NCT07488676Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the ...

Irving, TXPHASE1150 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT07535112Recruiting

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

Researchers are looking for a better way to treat people who have advanced or metastatic colorectal cancer (CRC) with a specific mutation, the G12D mutation, in a protein called KRAS. Colorectal canc...

Irving, TXPHASE1130 participantsBayer

View Study Details

NCT07644039Recruiting

Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies

The main purpose of the study is to evaluate the safety, tolerability and recommended dose of PM54 in combination with pembrolizumab. To assess the antitumor activity of PM54 in combination with pembr...

Irving, TXPHASE1119 participantsPharmaMar

View Study Details

NCT06028074Recruiting

Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies

GIM-122 is a first-in-class, humanized immunoglobulin G1 kappa dual functioning monoclonal antibody (DFA). This phase 1 / 2 study plans to evaluate the safety, tolerability, pharmacokinetics and clini...

Irving, TXPHASE1111 participantsGeorgiamune Inc

View Study Details

NCT07355075Recruiting

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

This is a Phase 2, randomized, double-blind, vehicle-controlled clinical study evaluating the efficacy and safety of GX-03 topical ointment in adult subjects with moderate to severe atopic dermatitis ...

Irving, TXPHASE2110 participantsTurn Therapeutics

View Study Details

NCT06975293Recruiting

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers

This early phase oncology trial will be conducted at various study centers to investigate the safety, tolerability, and antitumor activity of STC-15 (a METTL3 inhibitor) in combination with toripalima...

Irving, TXPHASE1107 participantsSTORM Therapeutics LTD

View Study Details

NCT06959706Recruiting

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

The primary objectives of this study are to evaluate the safety and tolerability of TGW101 and determine the recommended dosing regimen(s) for further study. The secondary objectives are to assess pha...

Irving, TXPHASE150 participantsTagworks Pharmaceuticals BV

View Study Details

About Atopic Dermatitis Clinical Trials in Irving

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 14 atopic dermatitis clinical trials recruiting participants in Irving, TX. These studies are seeking a combined 3,206 participants. Research is being sponsored by MediLink Therapeutics (Suzhou) Co., Ltd., Innovent Biologics (Suzhou) Co. Ltd., ArriVent BioPharma, Inc. and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Irving — FAQ

Are there atopic dermatitis clinical trials in Irving?

Yes, there are 14 atopic dermatitis clinical trials currently recruiting in Irving, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Irving?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Irving research site will contact you about next steps.

Are clinical trials in Irving free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Irving studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 14 active trials in Irving are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated July 22, 2026 from ClinicalTrials.gov